001438393 000__ 06723cam\a2200649\a\4500
001438393 001__ 1438393
001438393 003__ OCoLC
001438393 005__ 20230309004303.0
001438393 006__ m\\\\\o\\d\\\\\\\\
001438393 007__ cr\un\nnnunnun
001438393 008__ 210724s2021\\\\sz\\\\\\o\\\\\001\0\eng\d
001438393 019__ $$a1261304033$$a1266809407$$a1268573583$$a1284942775
001438393 020__ $$a9783030716974$$q(electronic bk.)
001438393 020__ $$a303071697X$$q(electronic bk.)
001438393 020__ $$z3030716961
001438393 020__ $$z9783030716967
001438393 0247_ $$a10.1007/978-3-030-71697-4$$2doi
001438393 035__ $$aSP(OCoLC)1261365499
001438393 040__ $$aEBLCP$$beng$$epn$$cEBLCP$$dYDX$$dEBLCP$$dGW5XE$$dOCLCO$$dDCT$$dOCLCF$$dDKU$$dOCLCQ$$dOCLCO$$dOCLCQ$$dCASUM
001438393 049__ $$aISEA
001438393 050_4 $$aR853.B54
001438393 08204 $$a610.28$$223
001438393 24500 $$aIdentification of biomarkers, new treatments, and vaccines for COVID-19 /$$cPaul C. Guest, editor.
001438393 260__ $$aCham :$$bSpringer,$$c2021.
001438393 300__ $$a1 online resource (229 pages)
001438393 336__ $$atext$$btxt$$2rdacontent
001438393 337__ $$acomputer$$bc$$2rdamedia
001438393 338__ $$aonline resource$$bcr$$2rdacarrier
001438393 347__ $$atext file
001438393 347__ $$bPDF
001438393 4901_ $$aAdvances in Experimental Medicine and Biology ;$$vv. 1327
001438393 4901_ $$aAdvances in experimental medicine and biology. Proteomics, metabolomics, interactomics and systems biology
001438393 500__ $$a11 Adaptive Immune Response and Age-Related Difference.
001438393 500__ $$aIncludes index.
001438393 504__ $$aReferences-3: COVID-19 Pandemic in Brazil: History, Characteristics, and Evolution-1 Brief Historical Facts of the COVID-19 Pandemic in Brazil-2 Governmental Measures to Combat the Pandemic-3 Regional Characteristics Influencing the COVID-19 Dissemination-4 Prevalence of the Disease in Different Subpopulations-5 Concluding Remarks-References-4: The Experiences of Recovered COVID-19 Patients in Baqiyatallah Hospital: A Qualitative Study-1 Introduction-2 Methods-2.1 Data Collection-2.2 Data Analysis-3 Results.
001438393 5058_ $$a5: Age-Specific Differences in the Severity of COVID-19 Between Children and Adults: Reality and Reasons -- 1 Introduction -- 2 Age-Related Effects of Different Infections -- 3 Age Effects of COVID-19 Disease -- 4 Clinical Features in Children -- 5 The Different Etiology and Severity of COVID-19 Based on Age -- 6 Underlying Conditions and Severity of COVID-19 in Children -- 7 Outdoor Activities and the Potential to Contract the Virus -- 8 Immune System and Age-Related Differences -- 9 Innate Immune Cells and Age-Related Differences -- 10 IFN and SARS-CoV in Children
001438393 5050_ $$aIntro -- Preface -- Contents -- Part I: Background -- 1: Genetic Aspects and Immune Responses in Covid-19: Important Organ Involvement -- 1 Introduction -- 2 Epidemiology -- 3 Main Coronavirus Groups -- 4 Genome, Genotype, and Protein Structure -- 5 Mechanism of Infection -- 6 COVID-19 Pathogenesis -- 7 Respiratory Manifestations -- 8 Extra-pulmonary Presentations -- 8.1 Gastrointestinal Manifestations -- 8.2 Cardiovascular Complications -- 8.3 Haematological Disorders -- 9 Immune Responses -- 10 Therapy -- 10.1 Drugs that Slow Viral Replication or Kill SARS-Cov-2
001438393 5058_ $$a10.2 Vaccination -- 11 Conclusion -- References -- Part II: Epidemiology -- 2: Prevalence of COVID-19 and the Continued Citizen-Based Control in Japan -- 1 Introduction -- 2 Cruise Ship Outbreak and the Environmental Assessment -- 2.1 COVID-19 Outbreak on the Diamond Princess Cruise Ship -- 2.2 Age-Related CFR Estimated from the Cruise Ship Outbreak -- 2.3 Environmental Assessment of SARS-CoV-2 on the Cruise Ship -- 3 Government-Recommended and Voluntary Measures to Protect Against COVID-19 Infection in Japan -- 4 Detection of the Coronavirus in Laboratories in Japan -- 5 Conclusions
001438393 5058_ $$a3.1 Theme I: Emotional-Sensational-Paradox -- Satisfaction-Dissatisfaction -- Positive Experiences-Negative Experiences -- Relaxation-Stress -- Support-Rejection -- 3.2 Theme II: Spiritual Growth -- Accepting and Submitting to Divine Providence -- Rethinking Material Possessions -- Seeking Stronger Divine Connection -- Tendency to Spirituality -- 3.3 Theme III: Experienced Mental-Psychological Effects -- Unpleasant Thoughts -- Perceived Mental Stress -- Positive Thoughts -- 4 Discussion -- 5 Conclusions -- References -- Part III: Risk Factors and Outcomes
001438393 506__ $$aAccess limited to authorized users.
001438393 520__ $$aThe novel coronavirus 2019 (COVID-19) has caused a serious global pandemic in just one year. Nearly every country and territory in the world has been affected by the virus. The virulence and infection rate of the virus are profound, and has required extreme social distancing measures across the globe in order to prevent overwhelming the healthcare services and hospitals. COVID-19 appears to have the greatest effects on elderly individuals and those who have co-morbid diseases, such as diabetes and obesity. As the cases and death rate remain high, there are justified fears of this virus remaining for several months or years to come. To address this, a rapid and unprecedented worldwide mobilization effort has begun to identify effective treatments and develop vaccines. As these begin to be deployed and administered across the globe, many now feel the virus will be brought under control and lives will eventually return to normal. This new volume will increase readers understanding of the ongoing COVID-19 pandemic through a series of chapters that address these concerns. Leading experts will discuss new treatment approaches, vaccine development, mental health aspects of the pandemic, and convey the results of survey studies. The book will be an excellent resource for researchers studying virology, metabolic diseases, respiratory disorders, and clinical scientists, physicians, drug companies, and healthcare services and workers.
001438393 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed August 5, 2021).
001438393 650_0 $$aBiochemical markers.
001438393 650_0 $$aCOVID-19 (Disease)
001438393 650_6 $$aMarqueurs biologiques.
001438393 650_6 $$aCOVID-19.
001438393 655_0 $$aElectronic books.
001438393 7001_ $$aGuest, Paul C.,$$eeditor.
001438393 77608 $$iPrint version:$$aGuest, Paul C.$$tIdentification of Biomarkers, New Treatments, and Vaccines for COVID-19.$$dCham : Springer International Publishing AG, ©2021$$z9783030716967
001438393 830_0 $$aAdvances in experimental medicine and biology ;$$vv. 1327.
001438393 830_0 $$aAdvances in experimental medicine and biology.$$pProteomics, metabolomics, interactomics and systems biology.
001438393 852__ $$bebk
001438393 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-030-71697-4$$zOnline Access$$91397441.1
001438393 909CO $$ooai:library.usi.edu:1438393$$pGLOBAL_SET
001438393 980__ $$aBIB
001438393 980__ $$aEBOOK
001438393 982__ $$aEbook
001438393 983__ $$aOnline
001438393 994__ $$a92$$bISE